Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DEA pseudoephedrine rule ups reporting threshold; Hatch pushes methamphetamine bill.

This article was originally published in The Tan Sheet

Executive Summary

SEN. HATCH AIMING FOR FLOOR CONSIDERATION OF METHAMPHETAMINE BILL in early September when Congress returns from its August recess. Sen. Orrin Hatch (R-Utah) still plans to "hotline" S 1965 through the Senate by unanimous consent despite publication of the Drug Enforcement Administration's final pseudoephedrine regs on Aug. 7. The bill attempts to restrain illicit production of methamphetamine by imposing, among other things, new controls on the sale of precursor substances such as pseudoephedrine and phenylpropanolamine ("The Tan Sheet" July 22, p. 3).
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085896

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel